AKTS Aktis Oncology Inc.

• $114M bought by 6 insiders
• $3M sold by 3 insiders outside a trading plan
• $259K sold by 1 insider under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Akos Czibere Chief Medical Officer
   Planned sale
   $259K 12,500 shares at $20.69 100% of stake
   Traded Sep 23 Filed Sep 24
   ↗
3. Ken Herrmann Director
   Sale
   $119K 4,856 shares at $24.56 100% of stake
   Traded Jul 20 Filed Jul 21
   ↗
4. Ken Herrmann Director
   Sale
   $77K 3,065 shares at $25.21 100% of stake
   Traded Jul 17 Filed Jul 20
   ↗
5. Shulamit Ron-Bigger COO
   Sale
   $1.4M 50,000 shares at $27.75 100% of stake
   Traded Jul 8 Filed Jul 10
   ↗
6. Akos Czibere Chief Medical Officer
   Sale
   $1.4M 50,000 shares at $27.77 100% of stake
   Traded Jul 8 Filed Jul 10
   ↗
7. Todd Foley Director
   Buy
   $4.2M 232,870 shares at $18.00 +5.8% to stake
   Traded Jan 12 Filed Jan 14
   ↗
8. Mpm Bioventures 2018, L.P. 10% owner, +7 joint filers
   Buy
   $20M 1,112,777 shares at $18.00 +12% to stake
   Traded Jan 12 Filed Jan 14
   ↗
9. Vida Ventures II, LLC 10% owner, +1 joint filer
   Buy
   $15M 835,000 shares at $18.00 New stake
   Traded Jan 12 Filed Jan 12
   ↗
10. EcoR1 Capital, LLC Director, +1 joint filer
    Buy
    $40M 2,222,222 shares at $18.00 New stake
    Traded Jan 12 Filed Jan 12
    ↗

Also filed in the last 12 months, not counted as buying or selling: 17 conversions and 6 option exercises.